about
Non-evidence-based ICD implantations in the United StatesDefining a Mobile Health Roadmap for Cardiovascular Health and DiseaseSupporting open access to clinical trial data for researchers: The Duke Clinical Research Institute-Bristol-Myers Squibb Supporting Open Access to Researchers InitiativeIs there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 studyAlabama coronary artery bypass grafting project: results from phase II of a statewide quality improvement initiativeOne-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry)Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarctionMedication performance measures and mortality following acute coronary syndromesRelationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromesImpact of race on cardiac care and outcomes in veterans with acute myocardial infarctionLong-term adherence with cardiovascular drug regimensImproving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiativeTreatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromesThe Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomesClopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital dischargeImpact of medication therapy discontinuation on mortality after myocardial infarctionGender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early ImplemeRacial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early IPatterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement InitiativeInfluence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromesThe Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)Pay for performance, quality of care, and outcomes in acute myocardial infarctionAtherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines databaseACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary InterventionClopidogrel use and long-term clinical outcomes after drug-eluting stent implantationACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus DocAcquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015The Society of Thoracic Surgeons National Database 2016 Annual Report.Introduction to the STS National Database Series: Outcomes Analysis, Quality Improvement, and Patient Safety.Impact of obesity on cardiovascular disease.Obesity and age of first non-ST-segment elevation myocardial infarction.Thickness dependence of the MoO(3) blocking layers on ZnO nanorod-inverted organic photovoltaic devicesUse of Open Access Platforms for Clinical Trial Data.Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort.Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction.Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operationsLong-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry.
P50
Q24607930-5BD7159F-9DF6-459E-9A4D-83ACEB7D370FQ26740573-8AB91F6F-0730-48A7-BC4E-6E53FDF2D867Q27007801-0E2F3418-C96D-489F-A479-6E37343694CBQ28165940-4915EE49-A496-41C3-93AC-633FB638270EQ28166554-5902A961-6387-4320-BBC9-D7194D7A2B05Q28169124-902FFC63-6F7F-40DE-A3E5-8F7E9EC6F1FEQ28185249-E65C8E83-18FE-4FC7-9150-8C0267906D3FQ28186198-D33059F0-CC0A-43BB-8ED1-F677A0FF9B60Q28191778-BE97C2E8-FF54-4EB0-842F-C66FFFFDCC46Q28192091-B513D30F-9055-41C4-8A63-F5F147E3C0FEQ28194045-1AB66D37-1D4E-4F2A-BD70-6182DC028243Q28194111-8FA7EBE8-15EC-45AC-A4FD-9257D7CCD3EDQ28194113-33885CAC-1ADD-4D3F-9281-13EF7FDF2E35Q28195416-1F4C9703-C521-4A03-B881-632D6693C440Q28196442-C90E4099-0CBB-4999-BE4A-9946C38E3DC3Q28200545-223C0A0A-026A-4B8F-8428-F39CE9DDD024Q28210289-43A733CE-4800-41E0-B02C-F49126A0D107Q28210531-ECC53787-FC59-4B34-BD68-6028FDFAA781Q28211512-56CB4247-FDF9-4C40-95C1-9AEB76BAE52DQ28211543-D0DF2973-F1F6-49F7-9595-26BDEE616ED9Q28211613-45EA9DF3-D7E7-401E-9FC7-AF9EA949F628Q28212516-FF0D9CD6-DFDD-4E12-9E69-3B540FA7AF49Q28221302-777C503F-9C48-446D-94BE-D20E68DCD18BQ28240355-920E3799-6FB4-44B9-A1E4-5D171F1BBF72Q28248714-3DF16E97-B86D-44A9-9825-72D9622CE9ADQ28265917-EC5F0194-977E-4210-ACDD-053D82DE0926Q28277375-70E52834-1453-483B-8AB3-6D9473051B32Q28282173-F347F8A6-AF13-477B-B38E-769FEA13B0D3Q28603731-42FA89BB-CFD9-40A5-BC4E-551FA5F2B7B1Q30275410-CEA61735-5A27-4927-839E-638DB2736B23Q30278418-1C8C7463-F70F-4772-91E4-039DB93F2703Q30371908-BF4C4B06-8801-4B36-BF61-E2D3F3378609Q30372006-78F59B64-1AC6-4773-9D9C-B8316D49806FQ30469744-DD31DEED-E9BA-41D9-978C-6BC0CDE7D4D4Q30489133-BBCA9CC5-9521-4BAA-B9C7-82D265AAD93EQ30567350-66490B56-7E1F-4B96-B025-8A697FCD1B02Q30576479-89016010-5AC0-46DA-A268-F5BC93FEBA20Q30577033-A66D38DB-A8F9-4EE0-9B62-0F46AA3F4519Q30579081-84A832CA-392C-426F-8C3F-882BE0EF22CEQ30585979-5B3BE06C-F586-4BD1-ABA6-7C8EE6140BCF
P50
description
American medical researcher
@en
name
Eric D Peterson
@ast
Eric D Peterson
@nl
Eric D. Peterson
@en
Eric D. Peterson
@es
type
label
Eric D Peterson
@ast
Eric D Peterson
@nl
Eric D. Peterson
@en
Eric D. Peterson
@es
altLabel
E D Peterson
@en
E Peterson
@en
E. D. Peterson
@en
E. Peterson
@en
Eric D Peterson
@en
Eric David Peterson
@en
Eric Peterson
@en
Peterson E
@en
Peterson E. D.
@en
Peterson E.
@en
prefLabel
Eric D Peterson
@ast
Eric D Peterson
@nl
Eric D. Peterson
@en
Eric D. Peterson
@es